LSTA — Lisata Therapeutics Balance Sheet
0.000.00%
- $29.49m
- -$14.11m
- 26
- 43
- 63
- 40
Annual balance sheet for Lisata Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25.2 | 34.6 | 95 | 69.2 | 50.5 |
Prepaid Expenses | |||||
Total Current Assets | 26 | 35.3 | 96.2 | 71.9 | 53.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.01 | 0.631 | 0.786 | 0.783 | 0.483 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 27.2 | 36 | 97 | 73 | 54.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 5.98 | 3.51 | 4.52 | 6.38 | 6.59 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.34 | 3.51 | 4.75 | 6.46 | 6.55 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 20.8 | 32.5 | 92.3 | 66.6 | 48.1 |
Total Liabilities & Shareholders' Equity | 27.2 | 36 | 97 | 73 | 54.7 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |